Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS
Marcell Szabo, Michiyo Iba, Avindra Nath, et al.
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 4, pp. 447-454
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

NLRP3 Inflammasome’s Activation in Acute and Chronic Brain Diseases—An Update on Pathogenetic Mechanisms and Therapeutic Perspectives with Respect to Other Inflammasomes
Anna Chiarini, Li Gui, C Viviani, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 999-999
Open Access | Times Cited: 23
Virus-induced brain pathology and the neuroinflammation-inflammation continuum: the neurochemists view
Jeswinder Sian‐Hülsmann, Peter Riederer
Journal of Neural Transmission (2024)
Open Access | Times Cited: 8
Long COVID and its association with neurodegenerative diseases: pathogenesis, neuroimaging, and treatment
Jinyang Zhao, Fan Xia, Xue Jiao, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 8
Review of organ damage from COVID and Long COVID: a disease with a spectrum of pathology
Andrew G. Ewing, Špela Šalamon, Etheresia Pretorius, et al.
Medical Review (2024) Vol. 5, Iss. 1, pp. 66-75
Open Access | Times Cited: 6
Post-acute Sequelae of SARS-CoV-2 Infection: A Neglected Public Health Issue
Zhonglei Wang, Liyan Yang
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 24
Clinical and Immunologic Effects of Paraprobiotics in Long-COVID Patients
María José Docampo, Mattei Batruch, Pietro Oldrati, et al.
Neurology Neuroimmunology & Neuroinflammation (2024) Vol. 11, Iss. 5
Open Access | Times Cited: 4
SARS-CoV-2 Invasion and Pathological Links to Prion Disease
Walter J. Lukiw, Vivian Jaber, Aileen I. Pogue, et al.
Biomolecules (2022) Vol. 12, Iss. 9, pp. 1253-1253
Open Access | Times Cited: 17
Identification of key genes and signaling pathway in the pathogenesis of Huntington's disease via bioinformatics and next generation sequencing data analysis
Basavaraj Vastrad, Chanabasayya Vastrad
Egyptian Journal of Medical Human Genetics (2025) Vol. 26, Iss. 1
Open Access
Role of toll-like receptors in post-COVID-19 associated neurodegenerative disorders?
Senthil Kumaran Satyanarayanan, Tsz Fung Yip, Zixu Han, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Need for awareness and surveillance of long-term post-COVID neurodegenerative disorders. A position paper from the neuroCOVID‐19 task force of the European Academy of Neurology
Dániel Bereczki, Ádám Dénes, Filippo Martinelli Boneschi, et al.
Journal of Neurology (2025) Vol. 272, Iss. 6
Open Access
SARS-CoV-2, long COVID, prion disease and neurodegeneration
Yuhai Zhao, Vivian Jaber, Walter J. Lukiw
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 13
Animal Models for the Study of Neurologic Manifestations Of COVID-19
Kelsey C Carpenter, Jibing Yang, Jiajie Xu
Comparative Medicine (2023) Vol. 73, Iss. 1, pp. 91-103
Open Access | Times Cited: 7
Toll-like receptor 2 deficiency ameliorates obesity-induced cardiomyopathy via inhibiting NF-κB signaling pathway
Chenchen Qian, Diyun Xu, Jiong Wang, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111551-111551
Closed Access | Times Cited: 2
Acute and long-term SARS-CoV-2 infection and neurodegeneration processes—circulus vitiosus
Weronika D. Krahel, Michalina Bartak, Joanna Cymerys
Acta Virologica (2024) Vol. 68
Open Access | Times Cited: 2
Moderate Binding between Two SARS-CoV-2 Protein Segments and α-Synuclein Alters Its Toxic Oligomerization Propensity Differently
Vince St. Dollente Mesias, Hongni Zhu, Xiao Tang, et al.
The Journal of Physical Chemistry Letters (2022) Vol. 13, Iss. 45, pp. 10642-10648
Open Access | Times Cited: 11
Cellular Sensors and Viral Countermeasures: A Molecular Arms Race between Host and SARS-CoV-2
Haoran Sun, Jasper Fuk‐Woo Chan, Shuofeng Yuan
Viruses (2023) Vol. 15, Iss. 2, pp. 352-352
Open Access | Times Cited: 5
Role of toll‐like receptors in the pathogenesis of COVID‐19: Current and future perspectives
Mingyan Yang, Mei‐Hua Zheng, Xiang‐Ting Meng, et al.
Scandinavian Journal of Immunology (2023) Vol. 98, Iss. 2
Open Access | Times Cited: 4
microRNA, the Innate-Immune System and SARS-CoV-2
James M. Hill, Walter J. Lukiw
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 7
SARS-CoV-2 Neuroinvasion, Inflammatory Neurodegeneration and Alzheimer's Disease
Yuhai Zhao, Walter J. Lukiw
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 6
Imaging Techniques: Essential Tools for the Study of SARS-CoV-2 Infection
Aurélie Deroubaix, Anna Kramvis
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 5
Investigating neurological symptoms of infectious diseases like COVID-19 leading to a deeper understanding of neurodegenerative disorders such as Parkinson's disease
Jing Zhang
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 4
Probing molecular pathways: Illuminating the connection between COVID‐19 and Alzheimer's disease through the endocannabinoid system dynamics
Sun Q, Jinyang Gao, Ran An, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 4
Closed Access
Hyperglycemia as a Risk Factor for Cardiovascular Disease Post- Acute Sequelae of SARS-CoV-2 Infection
Mohammad NK
Medical Journal of Clinical Trials & Case Studies (2024) Vol. 8, Iss. 2
Open Access
A Case Report of Worsening Alzheimer’s Disease Symptoms after COVID-19 Infection That Were Treated with <i>Yigan-san-gami</i>
Hyo-jeong Lee, Sunwoo Kwon, Yi-jae Kwon, et al.
The Journal of Internal Korean Medicine (2024) Vol. 45, Iss. 2, pp. 149-158
Open Access
Potential role of Mappain, a prenylated stilbene, in reducing SARS-CoV-2 envelope protein-induced inflammation
Farouc A. Jaffer, Toluwanimi E. Akinleye, Thomas Abu, et al.
Deleted Journal (2024) Vol. 1, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top